TradingView costs $14.95/month for basic features. Finviz puts real-time data behind a paywall. Most stock screeners force you to choose between live updates or free access. You can't have both — except you can, and I've been using it since early 2025 when I got tired of paying for features that should be standard.
A TradingView stock screener alternative doesn't need to match every bell and whistle TradingView offers. It needs to answer three questions fast: what's moving, what's cheap or expensive, and what's the technical setup. Vunelix does this with zero registration, zero paywalls, and live market data that refreshes without lag. NYSE, NASDAQ, AMEX — thousands of stocks with the same fundamentals and technicals you'd pay for elsewhere.
TradingView Stock Screener Alternative Review 2026
I tested Vunelix against TradingView's free tier and Finviz for three months. Same universe of stocks, same data points, different execution. TradingView's free screener limits you to one alert and delayed data unless you subscribe. Finviz gives you static snapshots with 15-minute delays on the free version. Vunelix loads live prices, lets you sort by any column, and switches between ten preset views without asking for a credit card.
The interface feels like a spreadsheet, not a charting platform. That's the point. When you're screening 3,000 NASDAQ stocks for momentum plays or dividend payers, you don't need candlestick charts cluttering the view. You need columns — ticker, price, volume, P/E, RSI, whatever matters for your setup — and the ability to filter fast.
I ran a simple test in February 2026: screen for NASDAQ stocks with P/E under 15, dividend yield above 3%, and positive earnings growth. TradingView's free screener timed out twice. Finviz showed results but with stale prices. Vunelix returned 47 stocks in under two seconds with live quotes.
Best TradingView Stock Screener Alternative Features
Vunelix splits its stock screener into ten presets. Overview shows market cap, price, and daily change — basics you'd check first thing in the morning. Performance breaks down 1-day, 1-week, 1-month, and YTD returns. Valuation surfaces P/E, P/B, PEG ratios, and forward P/E if available. Income Statement digs into revenue, net income, profit margins. Dividends shows yield, payout ratio, ex-dates, and annual amounts.
Technical is where day traders and swing traders live. RSI, MACD, Stochastic, Bollinger Bands, and multiple moving averages — 50-day, 100-day, 200-day SMA and EMA. You can sort by RSI to find oversold stocks under 30 or overbought above 70. Filter by volume to catch breakout candidates. The data updates live, so when a stock crosses above its 50-day MA, you see it immediately.
Custom filters let you stack conditions. Want NASDAQ tech stocks with market cap above $5B, P/E under 20, and RSI below 40? Add three filters, hit apply, done. No scripting required like TradingView's Pine Script. Just point-and-click filtering with greater than, less than, or between operators.
Country and Exchange Coverage
US stocks dominate the screener — NYSE, NASDAQ, AMEX — but Vunelix also covers 50+ global exchanges. UK, Germany, Japan, India, Australia. If you're hunting ADRs or international blue chips, the country filter narrows results without switching platforms. Most free screeners lock you into US-only data or charge extra for global coverage.
Free Stock Screener NYSE NASDAQ Data Quality
Live data matters when you're timing entries. I've lost money buying stocks based on 15-minute delayed quotes that looked cheap but already ran 3% higher. The free stock screener NYSE NASDAQ updates continuously during market hours. Price changes flash in real-time, volume ticks up as orders fill, and technical indicators recalculate with each refresh.
Fundamentals update after quarterly earnings. When Apple reported in January 2026, P/E ratios and EPS figures refreshed within hours, not days. Revenue growth percentages adjusted automatically. Forward guidance metrics appeared in the Earnings preset the same afternoon analysts published estimates.
But data quality doesn't mean much if you can't act on it fast. Vunelix lets you sort any column with one click. Click "Volume" to see the most actively traded stocks. Click "% Change" to catch the day's biggest movers. Click "Dividend Yield" to rank income stocks highest to lowest. TradingView's free screener forces you into predefined scans with limited sorting.
How to Use TradingView Stock Screener Alternative for Day Trading
Day traders need speed and volatility. Open the Performance preset, sort by volume, and look for stocks trading 2x or 3x their average daily volume. High volume + big price swings = tradeable setups. Then switch to the Technical preset and check RSI — anything above 70 might be topping, anything below 30 could bounce.
I run this scan every morning before 10 AM. February 14, 2026 — found a biotech stock up 12% on massive volume with RSI at 78. Waited for a pullback to the 50-day MA, entered long on the bounce, out 90 minutes later for a 4% gain. The setup only worked because I saw the volume spike and RSI divergence in real-time, not 15 minutes late.
Add filters for price range and market cap to avoid penny stocks and illiquid names. I screen for stocks priced between $10 and $200 with market cap above $500M. Keeps the results tradeable with tight spreads. TradingView's free version doesn't let you combine technical and fundamental filters this cleanly.
Screening for Dividend Stocks and Value Plays
Long-term investors care about fundamentals, not 5-minute price action. Vunelix's Dividends preset shows everything you need — yield, payout ratio, ex-dividend date, and annual dividend amount. Filter for yield above 4% and payout ratio under 70% to find sustainable income stocks. Then cross-check the Valuation preset for P/E under 20 and P/B under 3.
I screened for this combo in early March 2026 and found 23 NYSE stocks that fit. Sorted by dividend growth rate — companies that raised payouts consistently over the past five years — and narrowed it to six names. Three were REITs, two were utilities, one was a consumer staples play. All trading below their historical P/E averages, all yielding north of 5%.
TradingView's screener shows dividend data but buries it under layers of menus. Finviz's free version doesn't show payout ratios or ex-dates. Vunelix puts it all in one sortable table with live updates when dividends get announced or adjusted.
Balance Sheet and Cash Flow Screening
Value investors dig deeper than P/E ratios. The Balance Sheet preset shows total assets, liabilities, debt-to-equity, and current ratio. Cash Flow preset reveals operating cash flow, free cash flow, and capex. Want companies with strong balance sheets and positive free cash flow? Filter for debt-to-equity under 0.5 and free cash flow above $500M.
I ran this screen for industrial stocks in mid-February 2026. Found a machinery company with $2B in free cash flow, debt-to-equity at 0.3, and P/E at 14. Stock was flat for six months despite growing earnings 18% YoY. Bought it at $47, still holding at $52 as of March 20. The setup was obvious once I filtered for balance sheet strength and ignored price momentum.
Custom Filters and Preset Flexibility
The ten presets cover 90% of screening needs, but custom filters handle the edge cases. You can filter by any metric Vunelix tracks — market cap, volume, moving averages, earnings growth, return on equity, gross margins. Stack up to 20 filters at once if you want to get hyper-specific.
Example from my own scans: NASDAQ stocks with revenue growth above 15%, gross margin above 40%, P/E under 25, and price within 5% of 52-week highs. That's four filters across fundamentals, valuation, and technicals. Results came back in under three seconds with 19 stocks. TradingView's free screener choked at three simultaneous filters.
And you can save custom presets if you screen for the same criteria weekly. Name it, save it, load it next time without rebuilding filters from scratch. Fxpricing users screening for swing trades or value plays save hours by automating their filtering process.
NYSE Stock Screener Live Data vs Delayed Quotes
Delayed data kills timing. You see a stock breaking out, click to research, and by the time you're ready to buy, it's already up 2%. Live quotes eliminate that lag. Vunelix refreshes prices continuously during market hours — no 15-minute delay, no manual refresh button, no premium subscription required.
I tested this on March 10, 2026 with a high-volume NYSE stock that gapped up 8% at open. TradingView's free version showed the stock at $62 fifteen minutes after it hit $64. Finviz's free tier was stuck at $61.50 from pre-market. Vunelix showed $64.20 in real-time, which let me catch the pullback to $63 and enter clean.
For swing traders holding positions for days or weeks, 15-minute delays don't matter much. For day traders and scalpers, they're the difference between profit and loss. The stock screener with real-time data costs nothing and updates as fast as paid platforms.
Does Vunelix Replace TradingView Completely?
No. TradingView's strength is charting and technical analysis depth — advanced drawing tools, custom indicators, multi-timeframe layouts, alerts on price levels and indicator crossovers. Vunelix doesn't have any of that. It's a screener, not a charting platform. You find stocks on Vunelix, then chart them on TradingView or your broker's platform.
But for screening? Vunelix beats TradingView's free tier and matches Finviz's paid version. You get live data, custom filters, ten preset views, and global exchange coverage without paying $15/month. If you're spending 80% of your time screening and 20% charting, Vunelix handles the heavy lifting for free.
I still use TradingView for chart analysis after I've narrowed down candidates. But I stopped paying for TradingView's screener when I realized Vunelix gave me the same data faster and cleaner. The combination works — screen on Vunelix, chart on TradingView's free tier, execute trades through your broker.
Who Should Use This Free Stock Screener?
Value investors hunting undervalued stocks with strong fundamentals. Day traders scanning for volume spikes and momentum plays. Dividend investors building income portfolios. Swing traders looking for technical setups near support or resistance. Anyone tired of paying for basic screening features that should be free.
If you're a beginner, start with the Performance or Overview presets to get familiar with how stocks move daily. If you're experienced, jump straight to custom filters and stack conditions until you've isolated exactly what you're looking for. The learning curve is flat — if you've used any spreadsheet software, you already know how to use Vunelix.
And if you're trading international stocks or ADRs, the global exchange coverage saves you from juggling multiple platforms. Screen US and European stocks in one view, filter by country, compare valuations across markets.
TradingView Stock Screener Alternative Limitations
Vunelix doesn't do everything. No charting tools, no alerts, no backtesting, no custom indicators. You can't draw trendlines or mark support levels. You can't set alerts when RSI crosses 30 or price breaks above a moving average. Those features live on TradingView, ThinkorSwim, or your broker's platform.
The screener also doesn't cover options, futures, forex, or crypto. It's stocks only — equities from 50+ global exchanges. If you're screening for options flow or unusual volume in derivatives, you need a different tool.
And while the data is live during market hours, after-hours and pre-market coverage is limited. Extended Hours preset shows some activity, but not every stock updates outside regular trading hours. For overnight gap scanning, you might need supplemental data sources.
Comparing Vunelix to Finviz and Yahoo Finance Screeners
Finviz's free screener is solid but shows delayed quotes and limits filter combinations. The Elite version costs $40/month for real-time data and advanced filters — features Vunelix includes for free. Yahoo Finance's screener is clunky, slow to load, and buries important metrics under tabs and dropdowns. Vunelix loads faster and displays more data per screen.
I've used all three. Finviz wins on visual design and heatmaps. Yahoo Finance integrates news and analyst ratings cleanly. But for pure screening speed with live data and custom filters, Vunelix is faster and cheaper. Zero cost, zero registration, zero upsells.
Fxpricing users who switched from paid screeners in late 2025 reported cutting monthly subscription costs by $30-$50 without losing functionality. The only trade-off was giving up charting tools they already had elsewhere.
Why Free Stock Screeners with Live Data Are Rare
Real-time market data costs money. Exchanges charge licensing fees for live quotes. Most free screeners use delayed data to avoid those costs, then charge subscriptions for real-time access. Vunelix absorbs the data fees and keeps the screener free — no ads, no paywalls, no freemium tiers.
That business model doesn't make sense unless the platform monetizes elsewhere. Vunelix offers paid API access and premium widgets for professional users. Retail traders screening stocks get the full screener for free. It's the same strategy Robinhood used with commission-free trading — give away the core product, charge for premium features.
Will it stay free forever? No idea. But as of March 2026, it's still fully accessible with no signs of paywalls or feature restrictions creeping in.
Final Thoughts on Switching from TradingView
You don't need to delete TradingView. Use both. Screen on Vunelix because it's faster and free. Chart on TradingView because its technical tools are unmatched. Execute trades through your broker. The workflow takes five minutes to learn and saves $180/year if you were paying for TradingView's screener.
I made the switch in January 2025 when my TradingView subscription renewed and I realized I only used the screener 10% of the time. The rest was charting, which the free tier handles fine. Vunelix filled the gap without adding cost. A year later, I haven't missed the paid screener once.
Is Vunelix the best stock screener ever built? No. But is it the best free stock screener with live NYSE and NASDAQ data in 2026?
